Skip to main content
J

Jiangsu Fengshan Group Co., Ltd — Investor Relations & Filings

Ticker · 603810 Shanghai Stock Exchange Manufacturing
Filings indexed 1,164 across all filing types
Latest filing 2026-04-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603810

About Jiangsu Fengshan Group Co., Ltd

Jiangsu Fengshan Group Co., Ltd. specializes in the research, development, production, and distribution of agrochemicals and fine chemical intermediates. The company's primary product portfolio includes a wide range of herbicides, insecticides, and fungicides designed for diverse agricultural applications. Notably, it is recognized as a leading global manufacturer of Trifluralin, alongside other key technical grade products such as Quizalofop-p-ethyl and Butachlor. Operating with integrated manufacturing facilities, the group emphasizes technological innovation and quality control to meet international standards. Its operations encompass the synthesis of technical grade active ingredients and the formulation of finished products, serving both domestic and global markets. The company maintains a focus on sustainable agricultural solutions and the development of high-efficiency, low-toxicity chemical products.

Recent filings

Filing Released Lang Actions
关于聘任董事会秘书的公告
Board/Management Information Classification · 1% confidence The document is an official announcement by the company’s board regarding the appointment of a new board secretary (senior management position). It details the board resolutions, qualifications of the appointee, and related meeting dates. This clearly falls under Board/Management Information (MANG).
2026-04-27 Chinese
薪酬与考核委员会工作细则(2026年4月修订)
Governance Information Classification · 1% confidence The document is the detailed internal rules and procedures (“工作细则”) governing the company’s Board Remuneration and Appraisal Committee, covering composition, responsibilities, meeting and voting procedures, conflict of interest rules, and other governance processes. This is a governance practice document, not an announcement, financial report, or proxy statement. It aligns with the definition of Governance Information (Code: CGR).
2026-04-27 Chinese
2025年度主要经营数据公告
Regulatory Filings Classification · 1% confidence The document is a Shanghai Stock Exchange–mandated announcement titled “2025年度主要经营数据公告,” disclosing product volumes, sales, revenues, and price changes for the full year, but it does not include full financial statements, net profit, earnings per share, or an audit opinion. It is not an Annual Report (10-K), Audit Report (AR), Earnings Release (ER), Interim/Quarterly Report (IR) or any of the other specific event filings. This type of routine operational statistics disclosure falls under general regulatory filings. Thus it is classified as RNS.
2026-04-27 Chinese
战略委员会工作细则(2026年4月修订)
Governance Information Classification · 1% confidence The document is the “Board Strategy Committee Working Rules” of Jiangsu Fengshan Group Co., Ltd., detailing internal rules, committee composition, duties, meeting procedures, and governance practices. This is a charter-style governance document rather than an annual or interim report, earnings release, or transaction announcement. It clearly falls under governance information (internal rules and board structure).
2026-04-27 Chinese
关于2026年度提供担保额度预计的公告
Regulatory Filings Classification · 1% confidence The document is a corporate announcement detailing the expected guarantee limits for the company’s subsidiaries in 2026, including amounts, internal approvals, risk disclosures, and board opinions. It is not a full annual or interim financial report, not a voting result notice, not an earnings release, nor any other specialized filing type. It does not merely announce the publication of another report. Therefore, it falls into the general regulatory announcements or miscellaneous filings category (RNS).
2026-04-27 Chinese
关于2026年度开展金融衍生品交易业务的公告
Regulatory Filings Classification · 1% confidence The document is a Chinese A-share regulatory announcement by Jiangsu Fengshan Group describing the board-approved proposal to conduct financial derivatives trading for hedging purposes, including details on transaction limits, instruments, risk management, and approval processes. It is not a financial report, earnings release, management change notice, or proxy statement, but rather a standard regulatory disclosure of a corporate decision. Thus, it best fits the general Regulatory Filings category.
2026-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.